01/27/2025
7:25 PM | MORTIMER IAN (Reporting)
Xenon Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/27/2025
7:28 PM | MORTIMER IAN (Reporting)
Xenon Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/24/2025
4:13 PM | MORTIMER IAN (Reporting)
Xenon Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/23/2025
5:34 PM | MORTIMER IAN (Reporting)
Xenon Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/17/2025
8:01 AM | Xenon Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/19/2024
5:57 PM | AULIN SHERRY (Reporting)
Xenon Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/18/2024
4:50 PM | AULIN SHERRY (Reporting)
Xenon Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/22/2024
6:48 PM | PATOU GARY (Reporting)
Xenon Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/22/2024
5:55 PM | PATOU GARY (Reporting)
Xenon Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/12/2024
9:40 AM | FMR LLC (Filed by)
Xenon Pharmaceuticals (Subject)
| Form SC 13G/A | |
08/08/2024
3:36 PM | Xenon Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
Get the Latest News and Ratings for XENE and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Xenon Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. |
07/12/2024
8:44 PM | PIMSTONE SIMON N. (Reporting)
Xenon Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/12/2024
4:32 PM | ROBIN SHERRINGTON (Reporting)
Xenon Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/05/2024
4:42 PM | GANNON STEVEN (Reporting)
Xenon Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2024
4:42 PM | GAROFALO ELIZABETH A. (Reporting)
Xenon Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2024
4:42 PM | Gover Justin D. (Reporting)
Xenon Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2024
4:42 PM | Machado Patrick (Reporting)
Xenon Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2024
4:43 PM | PATOU GARY (Reporting)
Xenon Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2024
4:41 PM | Svoronos Dawn (Reporting)
Xenon Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2024
4:41 PM | Cannon Gillian (Reporting)
Xenon Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2024
4:30 PM | PIMSTONE SIMON N. (Reporting)
Xenon Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/05/2024
3:22 PM | Xenon Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
06/05/2024
3:12 PM | Xenon Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/09/2024
3:09 PM | Xenon Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/26/2024
3:26 PM | Xenon Pharmaceuticals (Filer)
| Form DEF 14A | |
04/19/2024
3:21 PM | Xenon Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/12/2024
5:41 PM | AULIN SHERRY (Reporting)
Xenon Pharmaceuticals (Issuer)
Xenon Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/12/2024
5:42 PM | Von Seggern Christopher (Reporting)
Xenon Pharmaceuticals (Issuer)
Xenon Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/12/2024
5:33 PM | MORTIMER IAN (Reporting)
Xenon Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/12/2024
5:34 PM | DiFabio Andrea (Reporting)
Xenon Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/12/2024
5:35 PM | ROBIN SHERRINGTON (Reporting)
Xenon Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/12/2024
5:37 PM | EMPFIELD JAMES R. (Reporting)
Xenon Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/12/2024
5:38 PM | KENNEY CHRISTOPHER JOHN (Reporting)
Xenon Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
7:09 PM | GAROFALO ELIZABETH A. (Reporting)
Xenon Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/08/2024
5:47 PM | GAROFALO ELIZABETH A. (Reporting)
Xenon Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/08/2024
4:27 PM | Xenon Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/08/2024
4:28 PM | GANNON STEVEN (Reporting)
Xenon Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/08/2024
4:31 PM | ROBIN SHERRINGTON (Reporting)
Xenon Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2024
6:03 PM | GANNON STEVEN (Reporting)
Xenon Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/07/2024
6:04 PM | ROBIN SHERRINGTON (Reporting)
Xenon Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/29/2024
3:36 PM | Xenon Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
Nvidia’s CEO: “This Will Be a Multitrillion-Dollar Industry." (Ad) If you missed out on the big boom in Nvidia…
Listen up, because according to Nvidia's own CEO…
Elon Musk’s new technology could help launch an entirely new multitrillion-dollar industry. You MUST act before March 17th. |
02/29/2024
3:10 PM | Xenon Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
